Back to the complete issue
Wednesday, 30 May 2018

Affordably priced meds and a politically committed government helped Egypt treat Hep C patients “at an unprecedented pace”

Affordably priced meds and a politically committed government has allowed Egypt to treat Hepatitis C patients “at an unprecedented pace,” Ted Alcorn writes for the Atlantic. Pharmaceuticals manufacturers were willing to make the treatment available at affordable prices once they recognized that the country would not be able to afford the initially high price at which they were being sold. “In poorer countries like Egypt, pharmaceutical companies have been more willing to offer drugs at or near the cost of manufacturing, to reflect the countries’ ability to pay.” Egypt’s ability to drive down the meds’ retail price, coupled with its aggressive screening and treatment disbursal campaigns, has set an example for countries working towards Hepatitis C elimination, Alcorn says. “Egypt has shown that dramatic improvements in public health are possible when drugs are priced affordably — and a government makes an effort to systematically deploy them.”

Other stories that caught our eye in an otherwise slow news day for Egypt in the international press:

  • Squash power duo of Mohamed El Shorbagy and Nour El Sherbini sat down for an interview with Gulf News.
  • The cartoon character Bakkar is helping bridge the gap between what it means to be Nubian and what it means to be Egyptian, writes Marlies Van Coillie for Thomson Reuters’ My Salaam.
  • Egypt is working to mediate a ceasefire in the latest flare up between Israel and Gaza by urging Hamas to halt military attacks on Israel, the Times of Israel reports.

Enterprise is a daily publication of Enterprise Ventures LLC, an Egyptian limited liability company (commercial register 83594), and a subsidiary of Inktank Communications. Summaries are intended for guidance only and are provided on an as-is basis; kindly refer to the source article in its original language prior to undertaking any action. Neither Enterprise Ventures nor its staff assume any responsibility or liability for the accuracy of the information contained in this publication, whether in the form of summaries or analysis. © 2022 Enterprise Ventures LLC.

Enterprise is available without charge thanks to the generous support of EFG Hermes (tax ID: 200-178-385), the leading financial services corporation in frontier emerging markets; SODIC (tax ID: 212-168-002), a leading Egyptian real estate developer; SomaBay (tax ID: 204-903-300), our Red Sea holiday partner; Infinity (tax ID: 474-939-359), the ultimate way to power cities, industries, and homes directly from nature right here in Egypt; CIRA (tax ID: 200-069-608), the leading providers of K-12 and higher level education in Egypt; Orascom Construction (tax ID: 229-988-806), the leading construction and engineering company building infrastructure in Egypt and abroad; Moharram & Partners (tax ID: 616-112-459), the leading public policy and government affairs partner; Palm Hills Developments (tax ID: 432-737-014), a leading developer of commercial and residential properties; Etisalat Misr (tax ID: 235-071-579), the leading telecoms provider in Egypt; and Industrial Development Group (IDG) (tax ID:266-965-253), the leading builder of industrial parks in Egypt.